Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence?

Health Policy

Volumn 111, Issue 2, 2013, Pages 135-148

  Mossialos, Elias ^a   Naci, Huseyin ^a   Courtin, Emilie ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Community pharmacists; Evidence based policy; Pharmacy practice; Policy change; Systematic review

Indexed keywords

CHRONIC DISEASE; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; MANAGEMENT; PHARMACIST; PHARMACY; PUBLIC HEALTH; REVIEW; SYSTEMATIC REVIEW;

COMMUNITY PHARMACY SERVICES; HEALTH POLICY; PHARMACISTS; POLICY MAKING; PROFESSIONAL ROLE;

EID: 84879273384     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2013.04.003     Document Type: Review

References (85)

1. Niessen L.W., Grijseels E.W., Rutten F.F. The evidence-based approach in health policy and health care delivery. Social Science & Medicine 2000, 51(6):859-869.
2. Black N., Donald A. Evidence based policy: proceed with care. Commentary: research must be taken seriously. BMJ 2001, 323(7307):275-279.
3. Foppe van Mil J.W., Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harvard Health Policy Review 2006, 7(1):155-168.
4. Chave J. Professionalism and liberalisation. EuroPharm Forum 2010.
5. World Health Organisation Role of the Pharmacist in the Health Care System 1990, WHO, Geneva.
6. International Pharmaceutical Federation Statement of policy on Good Pharmacy Education Practice 2000, FIP, The Hague.
7. Hepler C.D., Strand L.M. Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy 1990, 47(3):533-543.
8. Holland R.W., Nimmo C.M. Transitions, part 1: beyond pharmaceutical care. Am J Health Syst Pharm 1999, 56(17):1758-1764.
9. Smith M., Giuliano M.R., Starkowski M.P. In Connecticut: improving patient medication management in primary care. Health Affairs 2011, 30(4):646-654.
10. International Pharmaceutical Federation. Human resources - the 2012 FIP Global Pharmacy Workforce Report. The Hague: International Pharmacy Federation; 2012.
11. Habeed I., Deepack J., Jegan R. Pharmacists in the wider public health workforce - a review. Archives of Pharmacy Practice 2012, 3(2):166-169.
12. Bush J., Langley C.A., Wilson K.A. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Research in Social and Administrative Pharmacy 2009, 5(4):305-318.
13. Ordre des Pharmaciens Livre Blanc - La pharmacie d'officine en France. Bilans et perspectives 2008, Ordre des Pharmaciens, Paris.
14. Department of Health Pharmacy in England. Building on Strengths, Delivering the Future 2008, DoH, London.
15. Canadian Pharmacists Association Report to the House of Commons Standing Committee on Health. Examination into chronic diseases in Canada's aging population and the role of the pharmacist 2011, Canadian Pharmacists Association, Ottawa.
16. Bouvy M., Dessing R., Duchateau F. White paper on pharmacy in The Netherlands. Position on pharmacy, pharmacists and pharmacy practice 2011, Royal Dutch Pharmacists Association, Amsterdam.
17. Canadian Pharmacist Association. 2013; [accessed 18.03.13]. http://www.pharmacists.ca/.
18. Department of Health. 2013; [accessed 18.03.13]. http://www.dh.gov.uk/en/index.htm.
19. General Pharmaceutical Council. 2013; [accessed 18.03.13]. http://www.pharmacyregulation.org/.
20. Ordre des Pharmaciens. 2013; [accessed 18.03.13]. http://www.ordre.pharmacien.fr/.
21. Royal Dutch Pharmacists Association. 2013; [accessed 18.03.13]. http://www.knmp.nl/.
22. Shea B.J., Grimshaw J.M., Wells G.A., Boers M., Andersson N., Hanel C., et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007, 7:10.
23. Melchiors A., Correr C., Venson R., Pontarolo R. An analysis of quality of systematic reviews on pharmacist health interventions. International Journal of Clinical Pharmacy 2012, 34(1):32-42.
24. Bero L.A., Mays N.B., Barjesteh K., Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database of Systematic Reviews 2000, CD000336. (2).
25. Nkansah N., Mostovetsky O., Yu C., Cheng T., Beney J., Bond C.M., et al. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews 2010, CD000336. 7.
26. Chisholm-Burns M.A., Kim Lee J., Spivey C.A., Slack M., Herrier R.N., Hall-Lipsy E., et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Medical Care 2010, 48(10):923-933. 10.1097/MLR.1090b1013e3181e57962.
27. Royal S., Smeaton L., Avery A.J., Hurwitz B., Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Quality Safety Health Care 2006, 15(1):23-31.
28. Holland R., Desborough J., Goodyer L., Hall S., Wright D., Loke Y.K. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. British Journal of Clinical Pharmacology 2008, 65(3):303-316.
29. Castelino R.L., Bajorek B.V., Chen T.F. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Annals of Pharmacotherapy 2009, 43(6):1096-1106.
30. Robertson J., Walkom E., Pearson S.A., Hains I., Williamsone M., Newby D. The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature. International Journal of Pharmacy Practice 2010, 18(2):69-87.
31. Hanlon J.T., Lindblad C.I., Gray S.L. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?. American Journal of Geriatric Pharmacotherapy 2004, 2(1):3-13.
32. von Gunten V., Reymond J.P., Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharmacy World & Science 2007, 29(3):146-163.
33. Al-Jumah K.A., Qureshi N.A. Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review. Patient Prefer Adherence 2012, 6:87-100.
34. Van Wijk B.L., Klungel O.H., Heerdink E.R., de Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Annals of Pharmacotherapy 2005, 39(2):319-328.
35. Sinclair Hazel K., Bond Christine M., Stead Lindsay F. Community pharmacy personnel interventions for smoking cessation. Cochrane Database of Systematic Reviews 2004, (1).
36. Blenkinsopp A., Anderson C., Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. Journal of Public Health 2003, 25(2):144-153.
37. Dent L.A., Harris K.J., Noonan C.W. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy 2007, 27(7):1040-1051.
38. Santschi V., Chiolero A., Burnand B., Colosimo A.L., Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Archives of Internal Medicine 2011, 171(16):1441-1453.
39. Gordon J., Watson M., Avenell A. Lightening the load? A systematic review of community pharmacy-based weight management interventions. Obesity Reviews 2011, 12(11):897-911.
40. Ellitt G.R., Brien J.A., Aslani P., Chen T.F. Quality patient care and pharmacists' role in its continuity - a systematic review. The Annals of Pharmacotherapy 2009, 43(4):677-691.
41. Geurts M.M.E., Talsma J., Brouwers J.R.B.J., de Gier J.J. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. British Journal of Clinical Pharmacology 2012, 74(1):16-33.
42. Morgado M.P., Morgado S.R., Mendes L.C., Pereira L.J., Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. American Journal of Health-System Pharmacy 2011, 68(3):241-253.
43. Wubben D.P., Vivian E.M. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008, 28(4):421-436.
44. Charrois T.L., Zolezzi M., Koshman S.L., Pearson G., Makowsky M., Durec T., et al. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2012, 32(3):222-233.
45. Roughead E.E., Semple S.J., Vitry A.I. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. International Journal of Pharmacy Practice 2005, 13(1):53-70.
46. Finley P.R., Crismon M.L., Rush A.J. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy 2003, 23(12):1634-1644.
47. Collins C., Limone B.L., Scholle J.M., Coleman C.I. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Research and Clinical Practice 2011, 92(2):145-152.
48. Machado M., Bajcar J., Guzzo G.C., Einarson T.R. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. The Annals of Pharmacotherapy 2007, 41(10):1569-1582.
49. Machado M., Bajcar J., Guzzo G.C., Einarson T.R. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. The Annals of Pharmacotherapy 2007, 41(11):1770-1781.
50. Machado M., Nassor N., Bajcar J.M., Guzzo G.C., Einarson T.R. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. The Annals of Pharmacotherapy 2008, 42(9):1195-1207.
51. Bell S., McLachlan A.J., Aslani P., Whitehead P., Chen T.F. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Australian New Zealand Health Policy 2005, 2:29.
52. Rubio-Valera M., Serrano-Blanco A., Magdalena-Belio J., Fernandez A., Garcia-Campayo J., Pujol M.M., et al. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. The Annals of Pharmacotherapy 2011, 45(1):39-48.
53. Pickard A.S., Hung S.-Y. An update on evidence of clinical pharmacy services' impact on health-related quality of life. The Annals of Pharmacotherapy 2006, 40(9):1623-1634.
54. Morrison A., Wertheimer A.I. Evaluation of studies investigating the effectiveness of pharmacists' clinical services. American Journal of Health-System Pharmacy 2001, 58(7):569-577.
55. Elias M.N., Burden A.M., Cadarette S.M. The impact of pharmacist interventions on osteoporosis management: a systematic review. Osteoporosis International 2011, 22(10):2587-2596.
56. Bennett M.I., Bagnall A.M., Raine G., Closs S.J., Blenkinsopp A., Dickman A., et al. Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. The Clinical Journal of Pain 2011, 27(7):623-630.
57. Ramalho de Oliveira D., Brummel A.R., Miller D.B. Medication therapy management: 10 years of experience in a large integrated health care system. Journal of Managed Care Pharmacy 2010, 16(3):185-195.
58. Barnett M.J., Frank J., Wehring H., Newland B., VonMuenster S., Kumbera P., et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. Journal of Managed Care Pharmacy 2009, 15(1):18-31.
59. Salter C., Holland R., Harvey I., Henwood K. I haven't even phoned my doctor yet. The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. BMJ 2007, 334(7603):1101.
60. Holland R., Brooksby I., Lenaghan E., Ashton K., Hay L., Smith R., et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ 2007, 334(7603):1098.
61. Koshman S., Charrois T.L., Simpson S.H., McAlister F.A., Tsuyuki R.T. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Archives of Internal Medicine 2008, 168(7):687-694.
62. Fish A., Watson M.C., Bond C.M. Practice-based pharmaceutical services: a systematic review. International Journal of Pharmacy Practice 2002, 10(4):225-233.
63. Holland R., Battersby J., Harvey I., Lenaghan E., Smith J., Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart 2005, 91(7):899-906.
64. Charrois T.L., Durec T., Tsuyuki R.T. Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results. The Annals of Pharmacotherapy 2009, 43(1):118-122.
65. Cartwright N., Hardie J. Evidence-based policy: a practical guide to doing it better 2012, Oxford University Press, London.
66. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336(7650):924-926.
67. McCarney R., Warner J., Iliffe S., van Haselen R., Griffin M., Fisher P. The Hawthorne effect: a randomised, controlled trial. BMC Medical Research Methodology 2007, 7:30.
68. Fleurence R.L., Naci H., Jansen J.P. The critical role of observational evidence in comparative effectiveness research. Health Affairs 2010, 29(10):1826-1833.
69. Beland D. Policy change and health care research. Journal of Health Politics, Policy and Law 2010, 35(4):615-641.
70. Hacker J. Privatizing risk without privatizing the welfare state: the hidden politics of social policy retrenchment in the United States. American Political Science Review 2004, 98(2):243-260.
71. Leal J., Luengo-Fernandez R., Gray A., Petersen S., Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. European Heart Journal 2006, 27(13):1610-1619.
72. Vogeli C., Shields A.E., Lee T.A., Gibson T.B., Marder W.D., Weiss K.B., et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine 2007, 22(Suppl (3)):391-395.
73. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. American Journal of Geriatric Pharmacotherapy 2007, 5(4):345-351.
74. Linjakumpu T., Hartikainen S., Klaukka T., Veijola J., Kivelä S.-L., Isoaho R. Use of medications and polypharmacy are increasing among the elderly. Journal of Clinical Epidemiology 2002, 55(8):809-817.
75. Johnson Ja B.J. Drug-related morbidity and mortality: a cost-of-illness model. Archives of Internal Medicine 1995, 155(18):1949-1956.
76. Committee on Identifying Preventing Medication Errors Preventing Medication Errors: Quality Chasm Series 2007, The National Academies Press.
77. Ernst F.R., Grizzle A.J. Drug-related morbidity and mortality: updating the cost-of-illness model. Journal of the American Pharmaceutical Association 2001, 41(2):192-199.
78. National Collaborating Centre for Primary Care. Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. NICE Clinical Guideline 76, 2009; Available from: [accessed 28.01.13]. http://www.nice.org.uk/nicemedia/live/11766/43042/43042.pdf.
79. OECD Health at a Glance: Europe 2010 2010, OECD, Paris.
80. NHS Business Services Authority Prescription Pricing Division. Prescription Volume and Prescription Cost. NHS Business Services Authority 2010; [accessed 28.01.13]. http://www.nhsbsa.nhs.uk/PrescriptionServices/951.aspx.
81. Barros P.P. The black box of health care expenditure growth determinants. Health Economics 1998, 7(6):533-544.
82. Kanavos P. Overview of pharmaceutical pricing and reimbursement regulation in Europe. Japanese Pharmacology and Therapeutics 2003, 31(10):819-836.
83. Perraudin C., Brion F., Bourdon O., Pelletier-Fleury N. The future of pharmaceutical care in France: a survey of final-year pharmacy students' opinions. BMC Clinical Pharmacology 2011, 11:6.
84. Rollason V., Vogt N. Reduction of polypharmacy in the Elderly: a systematic review of the role of the pharmacist. Drugs & Aging 2003, 20(11):817-832.
85. Blenkinsopp A., Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. International Journal of Pharmacy Practice 2005, 13(4):231-240.